RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
Dragon Announces a Proposed Merger with a Profitable, Fully-integrated Pharmaceutical Company Vancouver, British Columbia
Dragon Pharmaceutical Inc. (TSX: DDD, OTC BB: DRUG) ("Dragon") is pleased to announce that it has entered into a letter of intent to combine with Oriental Wave Holding Ltd ("Oriental Wave") More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
National Heart, Lung, and Blood Institute – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Mar 2008 - 250 pages - $3,995
Affimed Therapeutics AG – Product Pipeline Review – Q4 2010
Dec 2010 - 33 pages - $500
Phage Biotechnology Corporation – Product Pipeline Review – Q4 2010
Dec 2010 - 25 pages - $500
Celldex Therapeutics, Inc. - SWOT Analysis
Nov 2010 - 20 pages - $125
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
Company Financials: AspenBio Pharma
Jan 2010 - $75
InNexus Biotechnology Inc. - Product Pipeline Review - Q4 2010
Dec 2010 - 70 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jul 2011 - 74 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human therapeutics del
Therapeutic target
Blood and forming organs del
Year
2004 del

Browse By

Therapeutic target
Blood composition
Blood disorders
Blood substitute
Blood Transfusion
Fibrogenesis
Hemorrhagic trauma
Lymphatic disorders
Sepsis
Thrombosis
Whole blood substitute

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us